Skip to main content

Wannan shafin yana aiwatar da ayyuka na asali kuma bai shirya don amfanin marasa lafiya ba tukuna.

Yana aiki

BioNTech

Pioneer of mRNA-based immunotherapies

Masu kera

Kasa
Germany
An kafa
2008
Birnin hedikwata
Adireshin hedikwata
An der Goldgrube 12, 55131 Mainz, Germany
Imel
info@biontech.de
Waya
+49 6131 90840

Game da

Founded in 2008 by Uğur Şahin and Özlem Türeci, BioNTech specializes in mRNA-based vaccines and cancer immunotherapies. Co-developed the first approved mRNA COVID-19 vaccine with Pfizer.

Allurar rigakafi

Ba'a sami bayanai ba

Tambayoyi

Ba'a sami tambayoyi ba.